BMC Cancer Oncology

Optimal early endpoint for second-line or subsequent immune checkpoint inhibitors in previously treated advanced solid cancers: a systematic review

Jingqiu Li, Xiaoding Zhou, Lei Wu, Jiabao Ma, Yan Tan, Songke Wu, Jie Zhu, Qifeng Wang, Qiuling Shi
Springer Nature · 2025-02-18 · DOI 10.1186/s12885-025-13712-0

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →